Livtencity Tablet, Coated
Product Images NDC 64764-800

5 FDA label images from Takeda Pharmaceuticals America, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Livtencity (NDC 64764-800). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Livtencity 01)

Chemical Structure (Livtencity 01)
Chemical structure of maribavir, showing a chlorinated aromatic ring attached to a fused heterocyclic ring system connected to a sugar moiety with hydroxyl groups.*
FDA Label Image

Logo (Logo01)

FDA Label Image

Logo (Logo02)

Logo (Logo02)
Livtencity 200 mg coated tablets carton by Takeda Pharmaceuticals America, Inc. The packaging displays the product name Livtencity prominently with the strength of 200 mg. The labeler name Takeda is visible on the top left corner. The form is oral tablet, with a simple white and gray design and the Takeda logo in the top left.*
FDA Label Image

Principal Display Panel (200 mg Bottle Carton)

Principal Display Panel (200 mg Bottle Carton)
Livtencity (maribavir) 200 mg coated tablets packaging label. The label indicates a dosage of 400 mg daily (two 200 mg tablets twice a day), containing 28 tablets per package. Distributed by Takeda Pharmaceuticals America, Inc. The design features a purple background with red and white accents and includes storage instructions and a barcode.*
FDA Label Image

Principal Display Panel (200 mg Bottle Carton 56 Tablets)

Principal Display Panel (200 mg Bottle Carton 56 Tablets)
Packaging label for Livtencity (maribavir) tablets 200 mg by Takeda Pharmaceuticals America, Inc. The label indicates a prescription oral tablet product with 56 tablets per bottle. It includes storage instructions, dosage information specifying 400 mg total daily dose, and warnings to keep away from children. The label features the Takeda logo and product barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.